EQ Healthcquisition Corp. Class A (EQHA) Financials

$10.06

$-0.03 (-0.30%)

As on 21-Dec-2022 16:00EDT

Market cap

$277 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

28.7

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	1.04	3.22	--	--	--	--
Operating Profit (EBIT)	-1.04	-3.22	0.00	--	--	--
Other Income	9.87	--	--	--	--	--
Profit before Tax	9.34	6.96	0.00	--	--	--
Provision for Tax	0.25	--	--	--	--	--
Profit after Tax (Net Income)	9.09	6.96	0.00	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	9.67	6.96	0.00	--	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-10.33	-0.02	0.02	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.09	0.02	--	--	--	--
Current Liabilities	1.85	0.00	0.19	--	--	--
Total Liabilities	2.46	0.22	0.21	--	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	221.14	0.22	0.19	--	--	--
Current Assets	0.41	0.00	0.02	--	--	--
Total Assets	223.40	0.00	0.21	--	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	-1.45	-1.74	-0.16	--	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-1.48	-1.48	--	--	--
Cash Flow from Investing Activities	--	-220.00	-220.00	--	--	--
Cash from Financing Activities	--	221.51	0.07	--	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	1.51	1.16	--	--	--	--
Cash EPS ($)	--	1.16	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.25	--	--	--	--
Free Cash Flow per Share ($)	--	-0.25	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	247,807.02	--	--	--	--
ROE (%)	--	247,807.02	--	--	--	--
ROA (%)	4.07	3,226.61	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	92.02	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	1,343.78	-107,153.00	--	--	--	--
Net Profit Growth (%)	-7,525.29	695,694.30	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	-105.14	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	28.74	8.38	--	--	--	--
Price / Book Value	1.32	-3,168.72	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-265.98	8.38	--	--	--	--
Close Price ($)	9.88	9.71	--	--	--	--
High Price ($)	9.88	9.99	--	--	--	--
Low Price ($)	9.67	9.57	--	--	--	--
Market Cap ($ Cr)	276.65	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	2.08	--	--	--
Current Ratio	0.22	0.14	0.12	--	--	--
Quick Ratio	0.22	--	--	--	--	--
Interest Coverage	34.55	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.